Women's Health Weekly articles from January 2004

Women's Health Weekly archives from January 2004

Second opinion from major center leads to better detection, treatment changes.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Women with breast cancer who seek a second opinion on their mammograms from experienced specialists at a major cancer center frequently get a new plan for their care, a new study shows. Some even...

Synthetic progestin damages, estrogen protects blood vessels in animal model.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Synthetic progestins may be the major cause of harmful side effects reported with hormone replacement therapy. University of South Florida researchers used a novel imaging technique to show that...

New human breast and ovarian cancer gene described.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- A new human breast and ovarian cancer gene has been described by a team of researchers in the U.K. and Canada. The gene, called EMSY, also characterizes a subset of breast cancer with poorer...

Low iron levels associate with hair loss in women.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Low iron levels associate with hair loss in women. "Alopecia in women is a common problem, and conflicting observational data have failed to determine whether an association exists between alopecia...

Finger length predicts sperm retrieval and pregnancy success after IVF/ICSI.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Finger length predicts sperm retrieval and pregnancy success after IVF/ICSI. According to published research from England, "the differentiation of the urogenital system and the appendicular skeleton...

Couples may be receiving too much information about their fetuses.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Couples may be receiving too much information about their fetuses. According to a study from England, "the amount of information available to couples about the health of their fetus is increasing....

Arbitrator: City council can't exclude voluntary procedure from health benefits.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Cincinnati, Ohio, must restore voluntary abortion coverage to city employee health benefits and reimburse any employee who has had an abortion since city council banned the coverage, an arbitrator...

TRAF6 has many essential functions spanning immune, bone, and nerve functions.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- TRAF6 has many essential functions spanning immune, bone, endocrine, and nerve functions. "Tumor necrosis factor (TNF) receptor associated factor 6 (TRAF6) is a crucial signaling molecule...

Antiemetic improves control of chemotherapy-induced nausea, vomiting.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- A post-hoc analysis of two Phase III trials for Emend (aprepitant) showed that treatment with Emend in combination with a 5-HT3 receptor antagonist and a corticosteroid ("regimen with Emend ")...

Hypoxic myocytes produce growth factor that stimulates COX-2 production.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Hypoxic myocytes produce growth factor that stimulates COX-2 production. According to published research from the United States, "there is increasing evidence that cyclooxygenase (COX)-2 possess...

Global Precision Medical licenses Thermal Ablation Technology.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Global Precision Medical, Inc., (GBPMF) announced that on December 2, 2003, it entered into an agreement to acquire an exclusive worldwide license from MDMI Technologies, Inc., (MDMI), of Richmond,...

A decreased level of ERbeta mRNA may be associated with breast tumorigenesis.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- A decreased level of ERbeta mRNA may be associated with breast tumorigenesis and DNA methylation is an important mechanism for ERbeta gene silencing in breast cancer, researchers say. "Two novel...

Advexin vaccine therapy to begin phase I/II.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Introgen Therapeutics, Inc., (INGN) announced that its vaccine therapy, INGN 225, will be evaluated at two U.S. cancer centers in a phase I/II study to treat patients with advanced breast cancer. ...

Analysis shows Faslodex effective in treating metastatic breast cancer.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Results from two pivotal phase III trials looking at overall survival demonstrate that Faslodex (fulvestrant) Injection is an effective alternative to Arimidex (anastrozole) Tablets in the treatment of...

Aromatase inhibitors' signal disruption mechanism differs from Tamoxifen.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Aromatase inhibitors for breast cancer alter estrogen-receptor signaling differently than tamoxifen, researchers say. According to a study from England, "Endocrine therapy with tamoxifen has been...

Breast cancer assay quantifies likelihood of breast cancer recurrence in study.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- The National Surgical Adjuvant Breast and Bowel Project (NSABP) and Genomic Health, Inc., announced that their large, prospective trial met its defined endpoints and validated that Genomic Health's...

Breast cancer risk from antibiotics may be due to altered immunity, microflora.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Breast cancer may develop with sustained antibiotic use due to influence on immunity as well as reduced intestinal microflora carcinogen processing. According to recent research published in the...

Breast imaging workstation designed to support advanced CAD applications.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- R2 Technology, Inc., a computer-aided detection (CAD) company, and MeVis BreastCare (MBC), GmbH, Co., KG, of Bremen, Germany, a developer of softcopy reading software for breast cancer diagnosis,...

Breast tissue differentiation using arterial spin tagging may detect cancer.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Breast tissue differentiation using arterial spin tagging (AST) can potentially detect cancer, researchers report. "An AST pulse sequence has been developed to measure T-1 and relative blood...

Cancer survivors speak out on treatment options.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- A large percentage of women with breast cancer would choose to undergo chemotherapy, even if it only reduced the risk of breast cancer mortality by 1%, states a survey presented at the 26th annual San...

Combination genomics technique greatly improves breast carcinoma detection.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Combining cytogenetic and DNA flow cytometric analyses of breast carcinomas significantly improves the information obtained by either technique used alone, researchers say. "The cytogenetic and DNA...

Combination therapy shows improved survival in breast cancer patients.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Genentech, Inc., (DNA) and Roche announced updated results from a clinical study evaluating Herceptin (Trastuzumab) in combination with Taxotere (docetaxel) as a first-line treatment for HER2 (human...

Combining various MRI techniques may help improve disease detection.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Researchers at Johns Hopkins say that combining various types of magnetic resonance imaging (MRI) techniques more accurately sorts cancers from benign masses in breast tissues than any single imaging...

Company presents data for the en-bloc breast biopsy system at RSNA.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Neothermia Corp., an emerging company focused on the development and marketing of minimally invasive systems for the diagnosis of cancer, announced the first clinical presentation of data for its...

Docetaxel-based regimen improves survival and disease-free survival, data show.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- A docetaxel (Taxotere)-based regimen reduced the relative risk of death in women with early stage breast cancer by 30% and lowered the relative risk of the cancer returning by 28% when compared to a...

Drug-induced apoptosis mechanism via DR-dependent pathway not fully understood.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Apoptosis in drug-resistant cells is induced via DR-independent pathways mediated by mitochondrial dysfunction, researchers report. According to recent research from Japan, "Apoptosis is a crucial...

Expression of transglutaminases displayed in human breast cancer.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Breast cancer displays an aberrant expression of transglutaminases (TGase), wherein the levels of TGases-2, 3, and 7 are related to node involvement and patient outcome, researchers say. According...

FDA approves computer-aided detection for digital mammography.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Fischer Imaging Corporation (FIMG) and R2 Technology, Inc., announced that approval has been granted by the U.S. Food and Drug Administration (FDA) for the use of R2's proprietary mammography CAD...

FDA grants fast-track status for drug in certain patients.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Data from an early phase, multi-center clinical trial suggest that GW572016, a reversible inhibitor of two growth factor receptors involved in the proliferation and survival of many solid tumors, in a...

First computer-aided detection on PACS demonstrated at meeting.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- R2 Technology, Inc., announced the industry's first computer-aided detection (CAD) on PACS (picture archiving and communications system) workstations, demonstrated at the 89th Scientific Assembly and...

Freezing technique kills majority of small malignant tumors.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- A technique already in use to freeze and kill benign breast masses also appears to kill small malignant breast tumors, new research from a clinical trial at the University of Michigan Comprehensive...

Gefitinib demonstrates early promise in advanced breast cancer.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Delegates at the 2003 San Antonio, Texas, Breast Cancer Symposium had an early glimpse of the therapeutic potential of the anticancer agent gefitinib (IRESSA, ZD1839) in the treatment of patients with...

Genes upregulated by hypoxia are strategic targets for cancer therapy.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Genes upregulated by hypoxia are strategic targets for cancer therapy. According to recent research published in the journal Biomedicine & Pharmacotherapy, "hypoxia is a stress that causes...

Herstatin inhibits heregulin-mediated breast cancer cell growth.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2, researchers say. "Ligands of the ErbB family of...

High-dose pre-SCT vinorelbine-paclitaxel regimen safe and effective.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- A high-dose VNB-PTX regimen is safe and effective for breast cancer patients prior to stem-cell transplantation. In a recent study, scientists in Italy evaluated "the safety, activity and...

NDA completed for treatment of breast cancer with brain metastases.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced that it has submitted to the U.S. Food and Drug Administration (FDA) the last component of its new drug application (NDA) for approval to market RSR13...

New antibody shows promise as agent for radioimmunotherapy of breast cancer.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced results from recent studies of the company's proprietary, humanized antibody, hRS7 (IMMU-112), which demonstrated that when the compound is labeled with iodine-131...

New data underlines Modrenal's genetic mechanism of action in breast cancer.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Bioenvision, Inc., (BIV) has presented new data underlining the ability of its lead breast cancer treatment, Modrenal (trilostane), to suppress the activity of estrogen at two groups of genes involved...

New drugs tested for effectiveness against advanced cases of disease.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- An experimental chemotherapy drug called Abraxane was more effective in treating advanced cases of breast cancer and carried fewer side effects than its widely used cousin Taxol, according to a study...

New studies launched with Modrenal.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Bioenvision, Inc., (BIV) announced its intention to conduct new studies in the U.K. in premenopausal, preoperative, and postmenopausal women for its lead breast cancer treatment Modrenal (trilostane)....

Performance audit praises state's oversight of mammography facilities.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Pennsylvania women can be assured that the Commonwealth is inspecting its mammography facilities regularly to verify that they comply with stringent federal quality standards and safety requirements,...

Physicians play key role in breast and cervical cancer screening compliance.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Researchers find that contact with a physician is most effective for promoting breast and cervical screening compliance. "The objective of this study was to examine mammography and cervical cancer...

Positive survival, quality of life data presented on RSR13 phase III study.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced the presentation of positive findings from its phase III clinical trial of the investigational radiation sensitizer RSR13 (efaproxiral). The results...

Postoperative pain from breast cancer surgery decreased without narcotics.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- I-Flow Corporation (IFLO) announced that results of a study of post-surgical pain relief after breast cancer surgery showed that the use of ON-Q Post Operative Pain Relief System following surgery for...

Review concludes Pennsylvania mammography facilities are inspected properly.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Problems turned up in 28% of Pennsylvania's inspections of certified mammography facilities, according to a report issued on December 4, 2003, by the state auditor general's office that praised how the...

Study evaluates recurrence in those switched from adjuvant tamoxifen to Arimidex.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Study results were presented that evaluated breast cancer recurrence rates in postmenopausal women who had been treated for 2-3 years with adjuvant tamoxifen and then switched to Arimidex (anastrozole)...

Study: Shows rhIGFBP-3 enhances sensitivity to Herceptin.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Insmed, Inc., (INSM) reported on data from recent studies of the company's proprietary anticancer compound, recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3). These studies...

Supraclavicular lymph node irradiation can reduce thyroid gland size.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Routine en face treatment of the supraclavicular lymph nodes, using the Hockey Stick method, should be reconsidered, researchers say. According to recent research published in the Yonsei Medical...

Taxotere compared with Taxol in metastatic breast cancer clinical trial.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- In a clinical trial, women treated with Taxotere (docetaxel) Injection Concentrate had a statistically significant improvement in overall survival and time to disease progression compared with those who...

Taxotere increases 5-year breast cancer survival rate in study.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Taxotere (docetaxel) administered as neo-adjuvant (pre-surgery) chemotherapy has been shown to significantly increase the 5-year survival rates of women with large or locally advanced breast cancer when...

Scalpel, scissor cause less damage, better results than electrocautery during BCT.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Scalpel plus scissor in breast conserving surgery cause less tissue damage and have better cosmetic results at the 3-year follow-up, researchers say. According to a study from Japan, "Breast...

Gel-filled breast implants approved as class III medical devices in the E.U.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Inamed Corp. (IMDC), a global healthcare company, announced the single lumen models of its silicone gel-filled breast implants have been certified as satisfying the European Union's (E.U.) safety and...

Study: HPV test is more effective than Pap smear for cervical cancer screening.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- A new study concludes that in women 30 and older, the HPV (human papillomavirus) DNA test is more effective than the Pap smear alone in identifying women with cervical cancer or its precursors. ...

Company demonstrates that CTLM detects tumor angiogenesis.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Imaging Diagnostic Systems, Inc., (IMDS) has confirmed that their Computed Tomographic Laser Breast Imaging System (CTLM) can depict angiogenesis associated with tumors. Dr. Eric Milne, professor...

Type 1 diabetes associated with increased risk of some cancers.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Certain forms of cancer occur more often in patients with type 1 diabetes compared with the general population in the corresponding sex and age groups. This has been shown in a new Swedish study from...

Cancer therapeutic candidate licensed to Myriad Genetics.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Maxim Pharmaceuticals (MAXM) announced the exclusive license of its MX90745 series of apoptosis-inducing compounds for the treatment of cancer to Myriad Genetics, Inc. Compounds in the MX90745...

Experts dispute link between abortion and breast cancer.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Abortion politics led Minnesota's Health Department to publish unreliable information about a link between abortions and breast cancer, state health workers wrote in e-mails obtained by the Star Tribune...

Genomics-derived (Lp-PLA2) inhibitor to advance to phase III trials.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) confirmed that its partner, GlaxoSmithKline, presented phase II clinical trial results and discussed its development plan for 480848, a lipoprotein-associated...

Hypertension is not the cause of increased CD risk during hormone replacement therapy.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Hypertension is not likely to underlie the heightened risk of heart disease associated with hormone replacement therapy. "In recent studies, it has been found that postmenopausal hormonal therapy...

GLUT1 protein expression is an indicator of hyperplasia grade cervical cancer.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- GLUT1 protein overexpression is an indicator of hyperplasia, transformation stages, and cervical cancer. "We studied whether induction of glucose transporters (GLUTs) 1 to 4 correlates with human...

Seungnoidan improves neurological signals in rodents without ovaries.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Seungnoidan improves neurological signals in rodents without ovaries. According to research from South Korea, "this study investigated the effects of Seungnoidan (SND), which has been widely used...

Cyclic changes experienced by women on oral contraception are significant.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Cyclic changes experienced by women on oral contraception are significant. "Despite the widespread use of oral contraceptives (OC) there is no consensus regarding their effect on menstrual cycle...

Young women in Greece have deficient knowledge about birth control methods.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Young women in Greece have deficient knowledge about birth control methods. "The aims of this study were to investigate the knowledge, attitudes and behavior of female high school and university...

Outpatient procedure shrinks benign breast lumps.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Breast cryotherapy is a safe, effective, and nearly painless office-based procedure that significantly reduces benign breast lumps without damaging breast structure, according to a study presented at...

Beers criteria for medications to avoid in the elderly are updated.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Forty-eight medications or classes of medications to avoid in adults age 65 or older have been identified by a expert panel in the U.S. charged with updating widely used criteria for potentially harmful...

Temporomesial activation associates with perceptions of body image.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Temporomesial activation associates with perceptions of body image. "Previous behavioral studies suggest that people who have an abnormal eating behavior may perceive information concerning body...

Wyoming makes help available for new mothers.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- First-time mothers can be faced with many questions and unknowns: What can I do during pregnancy to promote my baby's health? How can I afford to care for my child? How can I make my home safe for a...

Melatonin production shifts in people with depression.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Melatonin production shifts in people with depression. "In this study, serum melatonin and urinary 6-sulfatoxymelatonin (aMT6s) were measured in 14 major depressive inpatients, compared to 14...

Pregnant women in New York City and Krakow have significant phthalate exposures.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Pregnant women in New York City and Krakow have significant phthalate exposures. According to a study from the United States, "experimental evidence has shown that certain phthalates can disrupt...

Tests performed on amniotic fluid reveal prenatal exposure to toxic agents.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Tests performed on amniotic fluid reveal prenatal exposure to toxic agents. "Prenatal pesticide exposures may adversely affect children's health. However, exposure and health research is hampered...

More women than men now contracting HIV.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- If you think AIDS is a disease mostly of young men, think again. Women are the fastest-growing segment of people to contract the human immunodeficiency virus (HIV), the virus that causes AIDS. ...

Disgust sensitivity during menstruation varies with conception risk.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Disgust sensitivity across the human menstrual cycle varies with higher conception risk, not higher immunosuppression. "Disgust operates in many domains of behavior. On the presumption that facets...

Adenosine plays no role in decreased vascular resistance in twin pregnancies.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Adenosine plays no role in decreased vascular resistance in twin pregnancies. According to researchers in Japan, "we evaluated the possible role of increased adenosine in the regulation of...

Passive and active cigarette smoke disrupts the mechanics of placental growth.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Passive and active cigarette smoke disrupts the mechanics of placental growth. "Previously, we showed that maternal smoking harms human placental development by changing the balance between...

Vaccine company completes bridge loan; provides clinical update.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Avax Technologies, Inc., (AVXT) announced that it has closed a bridge financing in the aggregate principal amount of $925,000. The bridge notes mature on May 17, 2004, and bear interest at the rate...

Infections and other risk factors linked to premature birth, experts say.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Common infections of the genital tract account for up to 50% of preterm births, especially those that occur before 30 weeks, experts told a gathering of reporters and editors sponsored by the March of...

Endometrial receptivity biomarkers may improve infertility diagnosis, treatment.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Understanding the function of biomarkers of endometrial receptivity will help diagnose and treat infertile couples more efficiently, researchers report. According to recent research from Brazil,...

Moos factors depict menstrual cycle symptoms effectively.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Moos factors depict menstrual cycle symptoms effectively "Despite the wide usage of the Moos Menstrual Distress Questionnaire (MDQ) in menstrual cycle research, the factor structure of the...

Platelet-derived endothelial cell growth factor marks ovarian cancer behavior.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Platelet-derived endothelial cell growth factor marks ovarian cancer behavior. According to researchers in Japan, "we investigated the clinical significance of platelet-derived endothelial cell...

Rodent intrapelvic muscles are suited for modeling human pelvic floor disorder.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Rodent intrapelvic muscles are suited for modeling human pelvic floor disorder. According to a study from the United States, "in humans, the pelvic floor skeletal muscles support the viscera. Damage...

Sexology is an important element of a gynecologist's practice.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Sexology is an important element of a gynecologist's practice. According to a study from Switzerland, "sexology has become an integrated part of women's health care. Gynecologists therefore need to...

The silybin-phosphatidylcholine complex IdB 1016 might treat ovarian cancer.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- The silybin-phosphatidylcholine complex IdB 1016 might treat ovarian cancer. "This study aimed to assess, in an in vivo experimental model, the growth inhibitory effects of IdB 1016 (Silipide, a...

Infection with multiple HIV strains hastens disease progression.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Infection with multiple HIV strains hastens disease progression. "Human immunodeficiency virus type 1 (HIV-1)-infected individuals develop a genetically diverse virus population over time, but...

Leadership clarity and team innovation affects healthcare outcome.
January 1, 2004... 2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Researchers say leadership clarity is associated with clear team objectives, high levels of participation, commitment to excellence, and support for innovation. "The relationships among leadership...